A press conference is currently being given by European Medicines Agency (Coreper), which conducts research on the safety of the AstraZeneca coronavirus vaccine after the decision of European countries to suspend vaccinations due to concerns about possible side effects, such as cases of bleeding, clots and low platelet count.
According to Coreper, an investigation is underway into possible side effects from vaccine. At the same time, in the press conference it was mentioned that experts have been asked to investigate if there is a connection between the vaccine and the blood clots.
Experts will reach a conclusion on Thursday. The public will be informed immediately after Thursday’s meeting.
However, it was clarified that there is no indication that the vaccine caused thrombosis and that the number of such cases is not higher than that recorded in the population.
As the investigation continues, Coreper remains confident of the benefits of the vaccine and stresses that they outweigh the risks. Cases of blood clots are “extremely rare” and should be evaluated.
The head of the European Medicines Agency, Emer Cook, also noted that the service investigates the incidents one by one and a complete installation is expected on Thursday.
Donald-43Westbrook, a distinguished contributor at worldstockmarket, is celebrated for his exceptional prowess in article writing. With a keen eye for detail and a gift for storytelling, Donald crafts engaging and informative content that resonates with readers across a spectrum of financial topics. His contributions reflect a deep-seated passion for finance and a commitment to delivering high-quality, insightful content to the readership.
